Colgate-Palmolive Co. 10-Q Summary: Q1 2003
Business Context and Reporting Period
This filing is a Quarterly Report (Form 10-Q) for Colgate-Palmolive Co. for the three-month period ended March 31, 2003. The company operates globally in oral, personal, household surface and fabric care, and pet nutrition segments. As of April 30, 2003, there were 538,034,828 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q1 2003 | Q1 2002 |
|---|---|---|
| Net Sales | $2,348.4 million | $2,195.2 million |
| Gross Profit | $1,298.2 million | $1,202.8 million |
| Operating Profit | $510.5 million | $460.7 million |
| Net Income | $324.0 million | $289.7 million |
| Diluted EPS | $0.56 | $0.49 |
| Operating Cash Flow | $367.1 million | $274.1 million |
| Cash and Equivalents (End of Period) | $205.8 million | $184.8 million |
| Total Debt (Current + Long-term) | $3,596.0 million | $3,603.9 million |
Margins: Gross profit margin improved to 55.3% (from 54.8% in 2002). Operating profit margin reached 22% (from 21% in 2002). The effective tax rate was 32.0%.
Material Changes vs. Prior Period
- Sales Growth: Worldwide sales increased 7.0%, driven by a 6.0% gain in unit volume. Growth was broad-based across regions, with Europe (+19.5%) and Asia/Africa (+14.5%) showing the strongest reported sales increases, largely aided by favorable foreign currency translations.
- Profitability: Net income rose 12% year-over-year. Operating profit increased 11% due to volume gains, higher gross margins, and cost-control initiatives.
- Segment Performance:
- North America: Sales up 2.0% on 6.0% volume growth; operating profit up 3%.
- Latin America: Sales down 7.0% reported (due to currency), but up 17.0% excluding currency effects; operating profit down 6% reported.
- Pet Nutrition: Sales up 14.5% and operating profit up 34%.
- Cash Flow: Net cash provided by operations increased 34% to $367.1 million, attributed to improved profitability and timing of tax payments and benefit plan contributions.
Outlook, Risks, and Contingencies
Management Commentary: Management attributes growth to successful new product introductions (e.g., Colgate Total Plus Whitening, Softsoap Aromatherapy) and global sourcing initiatives. The company maintains a strong liquidity position and is in full compliance with debt covenants.
Legal Contingencies (Brazil):
- Central Bank Fine: A fine of approximately $75 million was imposed regarding foreign exchange filings related to the 1995 Kolynos acquisition. The company has appealed and suspended the fine, believing it will prevail.
- Tax Assessment: Brazilian authorities disallowed interest deductions and foreign exchange losses, resulting in an assessment of approximately $30 million. The company has appealed and intends to challenge this vigorously.
- Civil Action: Brazilian prosecutors are reviewing transactions related to the Kolynos divestiture. Management believes the company will ultimately prevail in these matters and does not expect a material impact on financial position.
Stockholder Proposals: At the May 6, 2003 annual meeting, stockholder proposals regarding stock-based compensation, workplace human rights, and an independent chairman were not approved.
Investor Verification Checklist
- Verify the sustainability of volume growth (6.0%) versus currency impacts, particularly in Latin America and Europe.
- Monitor the resolution of Brazilian legal contingencies (approx. $105 million in potential fines/assessments) and their impact on future cash flows.
- Review the company's ability to maintain gross margin expansion (55.3%) amidst rising media and promotional expenditures.
- Assess the impact of stock-based compensation on pro forma earnings (Diluted EPS would be $0.54 under FAS 123).
- Confirm continued compliance with debt covenants regarding operating cash flow to debt ratios.